A large number of oral antidiabetic drugs, which exert their effects through various mechanisms, aimed at eliminating three major metabolic disorders leading to hyperglycemia: dysfunction of β-cells, peripheral insulin resistance, excessive hepatic glucose production [7]. Here, INS is linked to metabolic disease.